Log in to search using one of your social media accounts:

 

LivaNova closes $225m ImThera buyout
LivaNova (NSDQ:LIVN) closed the $225 million buyout of ImThera Medical and its implantable sleep apnea treatment, according to ImThera co-founder Spencer Trask & Co. said today. San Diego-based ImThera’s flagship product is the Aura6000, an implanted hypoglossal nerve stimulator that uses a pair of implanted components, one near the collarbone and one in the upper neck, to stimulate tongue muscles to help control upper airway flow and reduce or eliminate sleep apnea. The device won FDA investigational device exemption in November 2014 for a pivotal trial; Spencer Trask said toda...
Source: Mass Device - January 23, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Neuromodulation/Neurostimulation Respiratory Wall Street Beat ImThera Medical Inc. LivaNova spencertrask Source Type: news

Implant device offers rest for some sleep apnea patients
An FDA-approved device called "Inspire" is gaining popularity and offering hope for millions of patients with sleep apnea. David Begnaud speaks to one patient who says the implant "saved" her life. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - January 23, 2018 Category: Consumer Health News Source Type: news

ResMed tops Wall Street ’ s Q2 earnings forecast, despite $127m tax hit
The U.S. tax reform passed last year dealt a $127 million blow to ResMed (NYSE:RMD) during its fiscal second quarter, but the sleep apnea company still managed to top Wall Street’s consensus earnings forecast with its Q2 results. San Diego-based ResMed posted profits of $9.5 million, or 7¢ per share, on sales of $601.3 million for the three months ended Dec. 31, 2017, for a bottom-line slide of -87.6% on sales growth of 13.4% compared with fiscal Q2 2016. The profit decline was driven by the Dec. 22 enactment of the U.S. tax reform bill, which delivered a $126.6 million hit to ResMed’s books consistin...
Source: Mass Device - January 23, 2018 Category: Medical Devices Authors: Brad Perriello Tags: MassDevice Earnings Roundup Respiratory Wall Street Beat ResMed Inc. Source Type: news

"It saved my life": Sleep apnea patient finds rest with implant device
An estimated 22 million Americans suffer from sleep apnea, putting them at greater risk for diabetes, heart disease, stroke and memory loss (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - January 23, 2018 Category: Consumer Health News Source Type: news

Sleep apnea patient was given a ketamine overdose
A man in his 60s undergoing surgery for sleep apnea overdosed after the anesthesiologist grabbed the wrong bottle of ketamine and administered 10 times the intended amount. (Source: the Mail online | Health)
Source: the Mail online | Health - January 22, 2018 Category: Consumer Health News Source Type: news

Sleep apnea and pesticide exposure in a study of US farmers - Baumert BO, Carnes MU, Hoppin JA, Jackson CL, Sandler DP, Freeman LB, Henneberger PK, Umbach DM, Shrestha S, Long S, London SJ.
INTRODUCTION: Carbamate and organophosphate pesticides inhibit acetylcholinesterase, and poisoning leads to respiratory depression. Thus, involvement in sleep apnea is plausible, but no data exist at lower levels of exposure. Other pesticides could impact ... (Source: SafetyLit)
Source: SafetyLit - January 17, 2018 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Sleep apnea and its role in transportation safety - Bonsignore M.
Obstructive sleep apnea (OSA) is a main cause of excessive daytime sleepiness and increases the risk for driving accidents, which can be normalized by treatment with continuous positive airway pressure ventilation. Since it is estimated that OSA is not dia... (Source: SafetyLit)
Source: SafetyLit - January 17, 2018 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Relationship between sleep quality, obstructive sleep apnea and sleepiness during day with related factors in professional drivers - Joorabbaf Motlagh S, Shabany M, Sadeghniiat Haghighi K, Nikbakht Nasrabadi A, Emami Razavi SH.
One of the important reasons for accidents is sleepiness.With this description, the sleep disorders are associated with health and mortality, and not only affect the person but also the family and the whole society. Aim of this study was assessing of relat... (Source: SafetyLit)
Source: SafetyLit - January 12, 2018 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

LivaNova launches VNS treatment-resistant depression trial
LivaNova (NSDQ:LIVN) said yesterday it launched a new trial of its VNS therapy system exploring its use treating patients with treatment-resistant depression and that it enrolled the first patient in the trial. The first patient in the trial was enrolled by Karl-Jürgen Bär of Germany’s Universitätsklinikum Jena, the London-based company said. “Treatment-resistant depression, or difficult-to-treat depression, is an area of mental health in need of additional proven treatment options. Up to one-third of patients suffering from depression do not respond to several attempts at treatmen...
Source: Mass Device - January 5, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Neuromodulation/Neurostimulation LivaNova Source Type: news

Sleep Apnea dev Invicta Medical raises $21m
Sleep apnea device developer Invicta Medical has raised approximately $21 million in a new round of equity financing, according to an SEC filing posted this week. The Palo Alto, Calif.-based company, founded in 2013, has not yet revealed the technology behind its development but claims that its solution to treating obstructive sleep apnea is non-invasive, customizable to meet patient needs and affordable, according to its website. The company has not yet officially stated how it plans to spend funds raised in the round. The round was joined by 6 anonymous investors, with the first sale in the round dated on December 20, 20...
Source: Mass Device - January 3, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Respiratory invictamedical Source Type: news

Invicta Medical raises $21m for sleep apnea device
Sleep apnea device developer Invicta Medical has raised approximately $21 million in a new round of equity financing, according to an SEC filing posted this week. The Palo Alto, Calif.-based company, founded in 2013, has not yet revealed the technology behind its development but claims that its solution to treating obstructive sleep apnea is non-invasive, customizable to meet patient needs and affordable, according to its website. The company has not yet officially stated how it plans to spend funds raised in the round. The round was joined by 6 anonymous investors, with the first sale in the round dated on December 20, 20...
Source: Mass Device - January 3, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Respiratory invictamedical Source Type: news

The association between sleep apnea and suicidal thought and behavior: an analysis of national survey data - Bishop TM, Ashrafioun L, Pigeon WR.
OBJECTIVE: Sleep disturbances have been associated with increased risk for suicidal thought and behavior. The literature in regard to sleep and suicide, however, has focused predominantly on generalized sleep disturbance or insomnia. The purpose of the cur... (Source: SafetyLit)
Source: SafetyLit - January 3, 2018 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Why this Houston health care co. is buying a sleep apnea co. for up to $225M
“We’re very bullish about the neuromodulation space.” (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - December 26, 2017 Category: Health Management Authors: Jack Witthaus Source Type: news

Why this Houston health care co. is buying a sleep apnea co. for up to $225M
“We’re very bullish about the neuromodulation space.” (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 26, 2017 Category: Biotechnology Authors: Jack Witthaus Source Type: news

Preterm infants have narrowed upper airways, which may explain higher obstructive sleep apnea risk
(Children's National Health System) A multidisciplinary team used MRI to determine that the risk factors that lead to obstructive sleep apena are confined to the uppermost airway and do not appear to be explained by enlarged adenoids and tonsils. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 22, 2017 Category: International Medicine & Public Health Source Type: news

Jazz Pharmaceuticals Submits New Drug Application for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnea
DUBLIN, Dec. 21, 2017 -- (Healthcare Sales & Marketing Network) -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration on December 20, 2017 seeking marketing appro... Biopharmaceuticals, FDA Jazz Pharmaceuticals, solriamfetol, narcolepsy, obstructive sleep apnea (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 21, 2017 Category: Pharmaceuticals Source Type: news

Jazz Pharmaceuticals Submits New Drug Application for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnea
DUBLIN, Dec. 21, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration on December 20, 2017 seeking marketing approval for solriamfetol... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - December 21, 2017 Category: Drugs & Pharmacology Source Type: news

Vivos BioTechnologies Advances Healthy Sleep By Addressing Sleep Apnea
Being at your best as an entrepreneur requires quality sleep. Vivos BioTechnology may be able to help. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 19, 2017 Category: Pharmaceuticals Authors: David K. Williams, Contributor Source Type: news

Vivos Advances Healthy Sleep By Addressing Sleep Apnea
Being at your best requires quality sleep. Vivos BioTechnologies can help. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 19, 2017 Category: Pharmaceuticals Authors: David K. Williams, Contributor Source Type: news

Researchers are developing light therapy as a non-invasive, alternative treatment for disease
(Natural News) Artificial light has both its risks and benefits, but a new study shows that it may be the solution to minimally invasive, drug-free treatments. Researchers are currently developing new ways using infrared neuromodulation to treat cardiac arrhythmia (irregular heart beat), hypertension (high blood pressure), asthma, sleep apnea (suspension of breathing during sleep), diarrhea, and... (Source: NaturalNews.com)
Source: NaturalNews.com - December 18, 2017 Category: Consumer Health News Source Type: news

Women Who Have Trouble Sleeping May Struggle With Infertility
BOSTON (CBS) – If you’re struggling to get pregnant, your sleep, or lack thereof, may be contributing. In a new study published in the journal Sleep, researchers looked at more than 50,000 women of reproductive age in Taiwan and found that those with sleep disorders other than sleep apnea had a more than three times greater likelihood of experiencing infertility compared to those who didn’t have trouble sleeping. The women with sleep problems were also more likely to have chronic health conditions like high blood pressure and thyroid issues, so it begs the question as to whether disordered sleep is just ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 18, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Healthwatch Local News Syndicated Local Dr. Mallika Marshall Local TV Pregnancy Sleeping Source Type: news

Zoll leads $59m Respicardia funding round
Respicardia said today it closed a $58.5 million financing round led by Zoll Medical to support commercialization efforts related to its Remede transvenous implantable neurostimulation system designed to treat patients with central sleep apnea. The Remedē system consists of a surgically placed battery pack and thin wires inserted into the blood vessels in the chest near the phrenic nerve, which it stimulates to engage the diaphragm to restore natural breathing during sleep and improve patient quality of life and satisfaction. The round was led by Zoll Medical and joined by all existing major investors, the Minne...
Source: Mass Device - December 18, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Neuromodulation/Neurostimulation Respiratory Respicardia Zoll Medical Corp. Source Type: news

Respicardia Closes $58.5 Million In Financing To Treat Central Sleep Apnea
Company announces strategic relationship with ZOLL Medical MINNETONKA, Minn., Dec. 18, 2017 -- (Healthcare Sales & Marketing Network) -- Respicardia, Inc., a private medical technology company, announced today that the company has closed a $58.5 millio... Devices, Venture Capital Respicardia, remedē System, ZOLL Medical, sleep apnea, neurostimulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 18, 2017 Category: Pharmaceuticals Source Type: news

Med-tech company Respicardia nabs $59M ahead of product launch
Med-tech company Respicardia Inc. has closed on $58.5 million in financing as it prepares to launch its device that treats sleep apnea in the U.S. Medical-device maker Zoll Medical Corp., based in Chelmsford, Mass., led the round of funding. Respicardia's previous investors also participated. The investment comes about two months after the U.S. Food and Drug Administration cleared Minnetonka-based Respicardia's product for sale in the U.S. The company's Remedē System is a pacemaker-like implantable… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 18, 2017 Category: Biotechnology Authors: Katharine Grayson Source Type: news

New guide aims to unmask unique challenges women face in getting healthy sleep
(Society for Women's Health Research) The unique barriers faced by women in maintaining good sleep health are often misunderstood or overlooked, according to a new resource 'Women& Sleep: A Guide for Better Health' developed by the Society for Women's Health Research (SWHR ® ) Interdisciplinary Network on Sleep. The Sleep Network also partnered with patients from MyApnea.org to develop 'Women& Sleep Apnea,' to raise awareness on a disorder that is widely perceived as a 'man's disease.' (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 18, 2017 Category: Cancer & Oncology Source Type: news

2017 Medtech Company of the Year: Readers & #039; Choice
Each year, MD+DI’s editors gather to choose which company should be named the Medtech Company of the Year, and it’s always a heated debate. This year, we named nine finalists, but the decision to crown Abbott as our 2017 Medtech Company of the Year was unanimous. Our readers, however, had a different opinion. While MD+DI’s editors chose Abbott for its ability to rise above challenges, Bigfoot Biomedical was the favorite among our readership. The Milpitas, CA-based firm is amalgamating other companies’ hardware plus its own software and algorithms to craft an artificial pancreas for patients with dia...
Source: MDDI - December 16, 2017 Category: Medical Devices Authors: Jamie Hartford Tags: Business Source Type: news

Sleep problems tied to female infertility
(Reuters Health) - Women with sleep disorders other than sleep apnea may be more than three times as likely to experience infertility as their counterparts who don ’t have trouble sleeping, a recent study suggests. (Source: Reuters: Health)
Source: Reuters: Health - December 15, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Report: Deal volumes still down, values up in medtech M & A
Mergers and acquisition deal volume are down but values are up in 2017, according to a new report form PitchBook. So far this year, approximately 210 deals have taken place in the healthcare devices and supplies industry, bringing in $62.5 billion. The number of deals is down from the 317 M&A deals that took place last year, though value has exceeded the $46 billion deal value from 216, according to the report. In the past week, over $535 million has cleared in mergers and acquisitions, including CryoLife Inc‘s (NYSE:CRY) $225 million acquisition of German stent graft and surgical graft maker Jotec, Smith &a...
Source: Mass Device - December 8, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Source Type: news

Is This the Deal LivaNova has Been Waiting For?
LivaNova isn't one to waste time. Just two weeks ago the London-based company unveiled plans to divest its cardiac rhythm management business (CRM) to MicroPort for $190 million in cash, a move that would allow the company to shift more focus to its areas of strength, including neuromodulation. This week, the company said it has agreed to pay up to $225 million to acquire San Diego, CA-based ImThera Medical. ImThera develops neurostimulation technology for the treatment of obstructive sleep apnea (OSA). The company's implantable device is designed to stimulate multiple tongue muscles via the hypogl...
Source: MDDI - December 6, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: Medical Device Business Source Type: news

Synthetic Cannabis-like Drug Effective for Sleep Apnea Synthetic Cannabis-like Drug Effective for Sleep Apnea
A phase 2 study of dronabinol, a synthetic THC compound, shows improvement compared with placebo in some key measures of sleep apnea, a condition with no available drug treatment.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 5, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

LivaNova puts $225m on the table for ImThera Medical
LivaNova (NSDQ:LIVN) said today that it agreed to a deal for ImThera Medical and its implantable sleep apnea treatment worth $225 million. San Diego-based ImThera’s flagship product is the Aura6000, an implanted hypoglossal nerve stimulator that won FDA investigational device exemption in November 2014 for a pivotal trial. The device uses a pair of implanted components, one near the collarbone and one in the upper neck, to stimulate tongue muscles to help control upper airway flow and reduce or eliminate sleep apnea. LivaNova, already in investor in ImThera, said it would pay $78 million up front ...
Source: Mass Device - December 5, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Neuromodulation/Neurostimulation Respiratory ImThera Medical Inc. LivaNova Source Type: news

Treating Sleep Apnea in Epilepsy Reduces Seizures Treating Sleep Apnea in Epilepsy Reduces Seizures
Treating obstructive sleep apnea in patients with epilepsy significantly reduces seizures, according to what's believed is the largest study of its kind to date.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 4, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Medical News Today: Cannabinoid drug found effective for treating sleep apnea
The largest and longest trial of a drug for obstructive sleep apnea finds the cannabinoid drug dronabinol safe and effective for treating the condition. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 4, 2017 Category: Consumer Health News Tags: Sleep / Sleep Disorders / Insomnia Source Type: news

People With Epilepsy May Gain From Common Sleep Apnea Treatment
Title: People With Epilepsy May Gain From Common Sleep Apnea TreatmentCategory: Health NewsCreated: 12/2/2017 12:00:00 AMLast Editorial Review: 12/4/2017 12:00:00 AM (Source: MedicineNet Sleep General)
Source: MedicineNet Sleep General - December 4, 2017 Category: Sleep Medicine Source Type: news

Treating Sleep Apnea May Subdue Seizures
(MedPage Today) -- Study suggests CPAP benefit in epilepsy patients with OSA (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - December 3, 2017 Category: Respiratory Medicine Source Type: news

Sleep Apnea Treatment Could Aid Epilepsy Patients
CPAP (continuous positive airway pressure) involves wearing an airflow mask over the nose or mouth each night, to help keep the back of the throat open for better breathing. (Source: WebMD Health)
Source: WebMD Health - December 2, 2017 Category: Consumer Health News Source Type: news

People With Epilepsy May Gain From Common Sleep Apnea Treatment
CPAP (continuous positive airway pressure) involves wearing an airflow mask over the nose or mouth each night, to help keep the back of the throat open for better breathing. (Source: WebMD Health)
Source: WebMD Health - December 2, 2017 Category: Consumer Health News Source Type: news

People With Epilepsy May Gain From Common Sleep Apnea Treatment
SATURDAY, Dec. 2, 2017 -- It's been used by many people to help ease sleep apnea, but new research suggests the CPAP mask may also help ease seizures in people with epilepsy. CPAP (continuous positive airway pressure) involves wearing an airflow... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 2, 2017 Category: General Medicine Source Type: news

Health Tip: Help Prevent Snoring
-- Snoring is not only an annoyance, but also a potential health concern. Chronic snoring may be associated with sleep apnea, which can lead to sleep deprivation and potential heart issues. The National Sleep Foundation says certain exercises may... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 1, 2017 Category: General Medicine Source Type: news

Synthetic cannabis could treat sleep apnea
A lab-produced form of synthetic cannabis may be an effective treatment for sleep apnea by helping to correct improper brain signals to the respiratory muscles, a University of Illinois study suggests. (Source: the Mail online | Health)
Source: the Mail online | Health - November 29, 2017 Category: Consumer Health News Source Type: news

Synthetic cannabis-like drug reduces sleep apnea
(Northwestern University) A synthetic cannabis-like drug in a pill reduced apnea and daytime sleepiness in the first large multi-site study of a drug for apnea. The drug targets the brain in a new treatment strategy. There is currently no drug treatment for sleep apnea, a sleep breathing disorder affecting about 30 million individuals in the US. Untreated apnea raises the risk of heart disease, diabetes, sleepiness, cognitive impairment and a motor vehicle accident. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 28, 2017 Category: International Medicine & Public Health Source Type: news

ResMed Elects Karen Drexler to its Board of Directors
A champion of women in leadership, Drexler brings wealth of experience at both commercial-stage and start-up medtech and healthcare companies Also at annual meeting of shareholders, long-serving Director Chris Roberts announced his retirement SAN DIE... Devices, Personnel ResMed, sleep apnea, chronic obstructive pulmonary disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 17, 2017 Category: Pharmaceuticals Source Type: news

Alzheimer's found to be a side effect of obstructive sleep apnea, study finds
(Natural News) People with obstructive sleep apnea are more likely to develop Alzheimer’s disease. This is due to the fact that those with this potentially serious sleep disorder have higher levels of amyloid beta, the peptides that have been strongly implicated in Alzheimer’s disease. This was the conclusion the researchers behind a compelling new study... (Source: NaturalNews.com)
Source: NaturalNews.com - November 16, 2017 Category: Consumer Health News Source Type: news

Study shows therapy improves quality of life in people who have sleep apnea
(American Academy of Sleep Medicine) A new study shows that positive airway pressure (PAP) therapy improves quality of life measures in people who have obstructive sleep apnea. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 16, 2017 Category: International Medicine & Public Health Source Type: news

Apple Watch can detect sleep apnea and high blood pressure
An app called Cardiogram tracks the body's heart rate and can alert a patient of abnormalities. It can detect sleep apnea with 90 percent accuracy and hypertension with 82 percent accuracy. (Source: the Mail online | Health)
Source: the Mail online | Health - November 14, 2017 Category: Consumer Health News Source Type: news

With Cardiogram's AI, Apple Watch can detect sleep apnea, hypertension, study shows
A new study showed that Cardiogram ’s deep neural network technology, called DeepHeart, can detect hypertension and sleep apnea. The study was recently presented at the American Heart Association.  (Source: mobihealthnews)
Source: mobihealthnews - November 14, 2017 Category: Information Technology Source Type: news

Shining a light on the nervous system to thwart disease
(Case Western Reserve University) Researchers from Case Western Reserve University School of Medicine, Vanderbilt University, and University of Pittsburgh have received a four-year, $9 million grant from the National Institutes of Health to develop enhanced infrared light technology (infrared neuromodulation) for potentially treating a variety of diseases, including cardiac arrhythmias, high and low blood pressure, asthma, sleep apnea and diarrhea, one of the leading killers of children worldwide. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 14, 2017 Category: International Medicine & Public Health Source Type: news

Sleep Apnea May Boost Alzheimer's Risk Sleep Apnea May Boost Alzheimer's Risk
A longitudinal study of cognitively normal older adults shows that biomarkers of increased amyloid burden increased over time in those with sleep apnea and in proportion to the severity of the condition.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - November 10, 2017 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Sleep Apnea May Boost Alzheimer's Risk
If your sleep is continually disrupted by a condition called sleep apnea, you might face a higher chance of developing Alzheimer's down the road. (Source: WebMD Health)
Source: WebMD Health - November 10, 2017 Category: Consumer Health News Source Type: news

Sleep Apnea May Boost Alzheimer's Risk
Source: HealthDay Related MedlinePlus Pages: Alzheimer's Disease, Seniors' Health, Sleep Apnea (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - November 10, 2017 Category: Consumer Health News Source Type: news